BD Medical
Bio Rad Laboratories
Novartis AG
F Hoffmann-La Roche
Abbott Laboratories
Danaher Corporation
BioMerieux
DiaSorin SpA
Siemens AG
Thermo Fisher Scientific
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHLAMYDIA INFECTION DIAGNOSTICS INDUSTRY
2.1 Summary about Chlamydia Infection Diagnostics Industry
2.2 Chlamydia Infection Diagnostics Market Trends
2.2.1 Chlamydia Infection Diagnostics Production & Consumption Trends
2.2.2 Chlamydia Infection Diagnostics Demand Structure Trends
2.3 Chlamydia Infection Diagnostics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Nucleic Acid Amplification Tests (NAATs)
4.2.2 Direct Fluorescent Tests
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Specialty Clinics
4.3.3 Diagnostic Centers
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Nucleic Acid Amplification Tests (NAATs)
5.2.2 Direct Fluorescent Tests
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Specialty Clinics
5.3.3 Diagnostic Centers
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Nucleic Acid Amplification Tests (NAATs)
6.2.2 Direct Fluorescent Tests
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Specialty Clinics
6.3.3 Diagnostic Centers
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Nucleic Acid Amplification Tests (NAATs)
7.2.2 Direct Fluorescent Tests
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Specialty Clinics
7.3.3 Diagnostic Centers
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Nucleic Acid Amplification Tests (NAATs)
8.2.2 Direct Fluorescent Tests
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Specialty Clinics
8.3.3 Diagnostic Centers
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Nucleic Acid Amplification Tests (NAATs)
9.2.2 Direct Fluorescent Tests
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Specialty Clinics
9.3.3 Diagnostic Centers
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 BD Medical
10.1.2 Bio Rad Laboratories
10.1.3 Novartis AG
10.1.4 F Hoffmann-La Roche
10.1.5 Abbott Laboratories
10.1.6 Danaher Corporation
10.1.7 BioMerieux
10.1.8 DiaSorin SpA
10.1.9 Siemens AG
10.1.10 Thermo Fisher Scientific
10.2 Chlamydia Infection Diagnostics Sales Date of Major Players (2017-2020e)
10.2.1 BD Medical
10.2.2 Bio Rad Laboratories
10.2.3 Novartis AG
10.2.4 F Hoffmann-La Roche
10.2.5 Abbott Laboratories
10.2.6 Danaher Corporation
10.2.7 BioMerieux
10.2.8 DiaSorin SpA
10.2.9 Siemens AG
10.2.10 Thermo Fisher Scientific
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
